Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma

被引:28
作者
Ramaswamy, M
Wallace, TL
Cossum, PA
Wasan, KM [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmaceut & Biopharmaceut, Vancouver, BC V6T 1Z3, Canada
[2] Aronex Pharmaceut Inc, The Woodlands, TX 77381 USA
关键词
D O I
10.1128/AAC.43.6.1424
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of this study was an interspecies comparison of free nystatin (NYS) and liposomal Nk'S (Nyotran) distribution in plasma. NYS and liposomal NYS at concentrations of 5, 10, and 20 mu g of NYS/ml were incubated in human, dog, and rat plasma For 5, 60, and 180 min at 37 degrees C. Following these incubations, plasma samples were separated into their high density lipoprotein (HDL), triglyceride-rich lipoprotein, low-density lipoprotein, and lipoprotein deficient plasma (LPDP) fractions by density-gradient ultracentrifugation, and each fraction was assayed for NYS by high-pressure liquid chromatography. Total plasma and lipoprotein cholesterol, triglyceride, and protein concentrations in each human, dog, or rat plasma sample were determined by enzymatic assays, When NYS and liposomal NYS were incubated in human, dog, or mt plasma, the majority of the NYS was recovered in the LPDP fraction. For the 5- and 60-min incubation times for all plasmas measured, a significantly greater percentage of NYS was recovered in the lipoprotein fraction (primarily HDL) following the incubation of liposomal NYS than following the incubation of NYS. There was a significant correlation between the lipoprotein lipid and protein profiles in human, dog, and rat plasmas and the distribution of NYS and liposomal NYS in plasma. In particular, differences in the proportion of plasma lipoprotein cholesterol, triglyceride, and apolar lipids (cholesteryl ester and triglycerides) carried by HDL influenced the distribution of NYS and liposomal NYS within plasmas of different species. These findings suggest that the distribution of NYS among plasma lipoproteins of different species is defined by the proportion of lipid carried by HDL, and this is possibly an important consideration when evaluating the pharmacokinetics, toxicities, and activities of these compounds following administration to different animal species.
引用
收藏
页码:1424 / 1428
页数:5
相关论文
共 25 条
[1]   Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins [J].
Cassidy, SM ;
Strobel, FW ;
Wasan, KM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1878-1888
[2]   THE ANTIMALARIAL DRUG HALOFANTRINE IS BOUND MAINLY TO LOW AND HIGH-DENSITY-LIPOPROTEINS IN HUMAN SERUM [J].
CENNI, B ;
MEYER, J ;
BRANDT, R ;
BETSCHART, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (05) :519-526
[3]   PHARMACOKINETICS AND TOXICITY OF CONTINUOUS INFUSION AMPHOTERICIN-B IN CANCER-PATIENTS [J].
CHABOT, GG ;
PAZDUR, R ;
VALERIOTE, FA ;
BAKER, LH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (04) :307-310
[4]   INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE [J].
CHAVANET, P ;
JOLY, V ;
RIGAUD, D ;
BOLARD, J ;
CARBON, C ;
YENI, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :963-968
[5]   DIFFERENCES IN PLASMA CHOLESTERYL ESTER TRANSFER ACTIVITY IN 16 VERTEBRATE SPECIES [J].
HA, YC ;
BARTER, PJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1982, 71 (02) :265-269
[6]  
HARMONY JAK, 1986, BIOCH BIOL PLASMA LI, P403
[7]   EFFECTS OF ELEVATION OF SERUM-CHOLESTEROL AND ADMINISTRATION OF AMPHOTERICIN-B COMPLEXED TO LIPOPROTEINS ON AMPHOTERICIN B-INDUCED TOXICITY IN RABBITS [J].
KOLDIN, MH ;
KOBAYASHI, GS ;
BRAJTBURG, J ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :144-145
[8]   ROLE OF LIPOPROTEINS AND ERYTHROCYTES IN THE INVITRO BINDING AND DISTRIBUTION OF CYCLOSPORIN-A IN THE BLOOD [J].
LEMAIRE, M ;
TILLEMENT, JP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (11) :715-718
[9]  
Lopez-Berestein G, 1988, Ann N Y Acad Sci, V544, P590, DOI 10.1111/j.1749-6632.1988.tb40459.x
[10]   PHARMACOKINETICS OF HALOFANTRINE IN MAN - EFFECTS OF FOOD AND DOSE SIZE [J].
MILTON, KA ;
EDWARDS, G ;
WARD, SA ;
ORME, ML ;
BRECKENRIDGE, AM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) :71-77